97 related articles for article (PubMed ID: 8757512)
1. The labelling index of primitive plasma cells determines the clinical behaviour of patients with myelomatosis.
Joshua D; Petersen A; Brown R; Pope B; Snowdon L; Gibson J
Br J Haematol; 1996 Jul; 94(1):76-81. PubMed ID: 8757512
[TBL] [Abstract][Full Text] [Related]
2. The functional phenotype of the primitive plasma cell in patients with multiple myeloma correlates with the clinical state.
Pope B; Brown RD; Gibson J; Petersen A; Wiley J; Joshua DE
Leuk Lymphoma; 1997 Sep; 27(1-2):83-91. PubMed ID: 9373199
[TBL] [Abstract][Full Text] [Related]
3. Multiple myeloma: relationship between light chain isotype suppression, labelling index of plasma cells, and CD38 expression on peripheral blood lymphocytes.
Joshua DE; Ioannidis R; Brown R; Francis SE; Gibson J; Kronenberg H
Am J Hematol; 1988 Sep; 29(1):5-11. PubMed ID: 3052044
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of CD38/45 flow cytometry and immunofluorescence microscopy to detect blood plasma cells in patients with plasma cell proliferative disorders.
Witzig TE; Meyers C; Therneau T; Greipp PR
Leuk Lymphoma; 2000 Jul; 38(3-4):345-50. PubMed ID: 10830741
[TBL] [Abstract][Full Text] [Related]
5. The bone marrow plasma cell labeling index by flow cytometry.
Pope B; Brown R; Gibson J; Joshua D
Cytometry; 1999 Dec; 38(6):286-92. PubMed ID: 10589044
[TBL] [Abstract][Full Text] [Related]
6. The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell.
Billadeau D; Ahmann G; Greipp P; Van Ness B
J Exp Med; 1993 Sep; 178(3):1023-31. PubMed ID: 8350044
[TBL] [Abstract][Full Text] [Related]
7. Dual CD38 and DNA staining of plasma cells in monoclonal gammopathies attained by a rapid, non-wash and automated method.
Gómez-Arbonés X; Gallart MA; Macià J
Clin Lab Haematol; 1996 Jun; 18(2):95-7. PubMed ID: 8866141
[TBL] [Abstract][Full Text] [Related]
8. Two subsets of peripheral blood plasma cells defined by differential expression of CD45 antigen.
Schneider U; van Lessen A; Huhn D; Serke S
Br J Haematol; 1997 Apr; 97(1):56-64. PubMed ID: 9136942
[TBL] [Abstract][Full Text] [Related]
9. Multiple myeloma: expression of nucleoside transporters on malignant plasma cells and their relationship to cellular proliferation.
Petersen AJ; Brown RD; Pope BB; Jamieson GP; Paterson AR; Gibson J; Wiley JS; Joshua DE
Leuk Lymphoma; 1994 May; 13(5-6):491-9. PubMed ID: 8069194
[TBL] [Abstract][Full Text] [Related]
10. Detection of myeloma cells in the peripheral blood by flow cytometry.
Witzig TE; Kimlinger TK; Ahmann GJ; Katzmann JA; Greipp PR
Cytometry; 1996 Jun; 26(2):113-20. PubMed ID: 8817086
[TBL] [Abstract][Full Text] [Related]
11. A new staging system for multiple myeloma based on the number of S-phase plasma cells.
San Miguel JF; García-Sanz R; González M; Moro MJ; Hernández JM; Ortega F; Borrego D; Carnero M; Casanova F; Jiménez R
Blood; 1995 Jan; 85(2):448-55. PubMed ID: 7811998
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
Kara IO; Sahin B; Paydas S; Cetiner S
Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
[TBL] [Abstract][Full Text] [Related]
13. Plasma cells in peripheral blood stem cell harvests from patients with multiple myeloma are predominantly polyclonal.
Pope B; Brown R; Gibson J; Joshua D
Bone Marrow Transplant; 1997 Aug; 20(3):205-10. PubMed ID: 9257888
[TBL] [Abstract][Full Text] [Related]
14. Detection of peripheral blood myeloma cells by three-color flow cytometry.
Witzig TE; Kimlinger TK; Greipp PR
Curr Top Microbiol Immunol; 1995; 194():3-8. PubMed ID: 7895502
[No Abstract] [Full Text] [Related]
15. Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myeloma.
Kimlinger T; Witzig TE
Bone Marrow Transplant; 1997 Mar; 19(6):553-6. PubMed ID: 9085734
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a monoclonal antibody to plasma cells: a comparison with CD38 and PCA-1.
Hata H; Matsuzaki H; Matsuno F; Sonoki T; Takemoto S; Kuribayashi N; Nagasaki A; Takatsuki K
Clin Exp Immunol; 1994 May; 96(2):370-5. PubMed ID: 8187346
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic and functional characterization of committed and primitive myeloid and lymphoid hematopoietic precursors in human fetal liver.
Roy V; Miller JS; Verfaillie CM
Exp Hematol; 1997 May; 25(5):387-94. PubMed ID: 9168060
[TBL] [Abstract][Full Text] [Related]
18. High proportions of VLA-5- immature myeloma cells correlated well with poor response to treatment in multiple myeloma.
Kawano MM; Mahmoud MS; Huang N; Lisukov IA; Mihara K; Tsujimoto T; Kuramoto A
Br J Haematol; 1995 Dec; 91(4):860-4. PubMed ID: 8547130
[TBL] [Abstract][Full Text] [Related]
19. Tc-99m methoxyisobutylisonitrile bone marrow imaging for predicting the levels of myeloma cells in bone marrow in multiple myeloma: correlation with CD38/CD138 expressing myeloma cells.
Ak I; Aslan V; Vardareli E; Gülbaş Z
Ann Hematol; 2003 Feb; 82(2):88-92. PubMed ID: 12601486
[TBL] [Abstract][Full Text] [Related]
20. Phenotyping primitive plasma cells.
Joshua D; Pope B; Brown R; Brown L; Murray A; Gibson J
Br J Haematol; 2002 Apr; 117(1):252-3. PubMed ID: 11918567
[No Abstract] [Full Text] [Related]
[Next] [New Search]
